Review
Published on 02 Apr 2024
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1380358
- 5,772 views
- 12 citations
Type at least 3 characters
1,586 articles
Original Research
Published on 28 Mar 2024
CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1380648
- 3,652 views
- 4 citations
Review
Published on 27 Mar 2024
Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1373548
- 4,586 views
Systematic Review
Published on 26 Mar 2024
Venetoclax combined chemotherapy versus chemotherapy alone for acute myeloid leukemia: a systematic review and meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1361988
- 2,945 views
Original Research
Published on 26 Mar 2024
Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1390438
- 1,501 views
Case Report
Published on 25 Mar 2024
A case report of atypical chronic myeloid leukemia with complete hematological and major molecular response to Venetoclax/Azacitidine treatment
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1327834
- 1,842 views
Original Research
Published on 22 Mar 2024
TNF-α is a predictive marker in distinguishing myeloproliferative neoplasm and idiopathic erythrocytosis/thrombocytosis: development and validation of a non-invasive diagnostic model
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1369346
- 1,894 views
Review
Published on 22 Mar 2024
Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1282300
- 5,266 views
- 5 citations
Original Research
Published on 21 Mar 2024
CD7-positive leukemic blasts with DNMT3A mutations predict poor prognosis in patients with acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1342998
- 2,490 views
Review
Published on 21 Mar 2024
A comprehensive review of the role of bone marrow biopsy and PET-CT in the evaluation of bone marrow involvement in adults newly diagnosed with DLBCL
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1301979
- 6,248 views
- 2 citations
Original Research
Published on 20 Mar 2024
NUP214 fusion genes in acute leukemias: genetic characterization of rare cases
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1371980
- 2,562 views
- 1 citation
Review
Published on 20 Mar 2024
Inflammation as a driver of hematological malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1347402
- 6,109 views
- 10 citations
Case Report
Published on 20 Mar 2024
Case report: A familial B-acute lymphoblastic leukemia associated with a new germline pathogenic variant in PAX5. The first report in Mexico
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1355335
- 2,259 views
- 1 citation
Case Report
Published on 19 Mar 2024
Case report: One case of acute myeloid leukemia M3 with atypical morphology
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1341840
- 2,181 views
Original Research
Published on 18 Mar 2024
Prognostic significance of β2-microglobulin decline index in multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1322680
- 2,560 views
- 3 citations
Original Research
Published on 15 Mar 2024
Risk factors analysis and the establishment of nomogram prediction model for PICC-related venous thrombosis in patients with lymphoma: a double-center cohort-based case-control study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1347297
- 2,715 views
- 2 citations